Daniel Anderson retweeted
Our @wikiguidelines letter to the editor regarding the controversy between IDSA and ATS on CAP guidelines is now published. Time for societies to modernize their approach to guidelines to STOP creating care standards based on opinions. @ABsteward @DrToddLee @AnilMakam @medrants
Daniel Anderson retweeted
Your Role: Review existing guidelines across all specialties to evaluate whether or not recommendations are based on high-quality, adequately powered, peer-reviewed, and publicly accessible prospective studies, including at least one randomized controlled trial
Daniel Anderson retweeted
📢📢📢Join our team appraising the level of evidence used to make consensus guideline recommendations across all specialties
Deadline to sign up: 6/20/25
New to WikiGuidelines?
Use the link below to complete WikiGuidelines New Participant application. forms.office.com/r/Tyb8R0iM8…
Daniel Anderson retweeted
This consensus statement creates a clinical guideline for the diagnosis and management of UTIs that addresses the gap between the evidence and recommendation strength. ja.ma/3UBBW90 @bradspellberg
Daniel Anderson retweeted
We are delighted to announce the publication of UTI WikiGuideline in JAMA Network Open. Thank you to the 54 experts from 12 countries for drafting. Special thanks to @zacroBID and @amenalor for leading the effort.
jamanetwork.com/searchresult…
Daniel Anderson retweeted
🆕️🔥The largest real-world, multicenter study of dalbavancin use for Gram-positive BSI @NicholasRebold @IDpharmresearch and many @SIDPharm 🌟s
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection #IDXposts #DOTS
link.springer.com/article/10…
Daniel Anderson retweeted
I see you @ABC_PharmD! Double Antibiotic Coverage Does Not Improve Outcomes in Febrile Neutropenia
pharmacypracticenews.com/Cli…
Daniel Anderson retweeted
🔥 NEW in OFID 🔥
👥 Retrospective cohort of admitted patients with ESBL UTI
💊 non-carbapenem beta-lactams (NCBLs) vs. carbapenems
Patients receiving NCBLs experienced:
☑️ no difference in LOS
☑️ higher rates of culture clearance
☑️ shorter DOTs
🔗 academic.oup.com/ofid/articl…
Daniel Anderson retweeted
A new study in OFID suggests that carbapenems may not be necessary in the treatment of patients with urinary tract infections caused by ESBL-producing organisms.
📄: bit.ly/3JAmWA1
#IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @D_AndersonID
Daniel Anderson retweeted
Congratulations🎉 to Dr. Daniel Anderson our Infectious Diseases/Internal Medicine pharmacist for his most recent publication! Way to go @D_AndersonID !! Follow the link below to read more. 🦠📰
Daniel Anderson retweeted
You've waited 41 years for this ...
A celebration Dawg Nation will never forget❗️ @GeorgiaFootball 🐶🏆
Daniel Anderson retweeted
🌟Excellent commentary🌟 @ICHEJournal @SHEA_EPI
Finding the balance between overtreatment versus undertreatment for hospital-acquired pneumonia #IDTwitter #MedEd #TwitteRx cambridge.org/core/journals/…
Daniel Anderson retweeted
"A person's ID knowledge is directly correlated with how much they hate Enterococcus and how much they love Doxycycline" @namarschalk #IDquotes #IDTwitter
Daniel Anderson retweeted
First tweetorial of the new academic year. Coagulase negative Staphylococci (CoNS) bacteremia is a frequent ID consult. So how do the pros handle the CoNS? Here is a quick generalized approach I use by creating a mnemonic out of CoNS. 1/10
Daniel Anderson retweeted
Bronchoalveolar lavage fluid specimens showed the high-
est positive rates (93%), followed by sputum (72%), nasal swabs (63%), fibrobronchoscope brush bi-
opsy (46%), pharyngeal swabs (32%), feces(29%), and blood (1%). None of the 72 urine
specimens tested positive. #COVID19
Daniel Anderson retweeted
#COVID2019 Cold or Flu? Can you tell?
Daniel Anderson retweeted
Just how contagious is COVID-19? This chart puts it in perspective.
Is this infographic accurate?! #COVID19 #idtwitter
popsci.com/story/health/how-…



















